Prof Juergen Reichardt ~ Adjunct Professor

Juergen Reichardt rejoined JCU (James Cook University; Australia) as an Adjunct Professor in the AITHM (Australian Institute of Tropical Health and Medicine) in retirement.

Juergen most recently served at YachayTech University, founded as the first research-intensive university in Ecuador, as the Vice Chancellor, Research and Innovation, equivalent to the role of a DVC Research in Australia or the UK or VP Research in the US or vice- or prorector for research in Europe. He previously served as the Head of School, Pharmacy and Molecular Sciences, (equivalent to a  Dean) at JCU as well as in other functions such as Associate Dean, Research for the Faculty of Health, Medicine and Molecular Sciences.

Furthermore, Juergen has a long scientific career beginning in biochemistry and molecular biology which evolved further into molecular epidemiology as well as his long and enduring commitment to human genetics and human genomics. He got his PhD at Stanford University witrh Paul Berg and postdoced at Baylor College of Medicine. Juergen was an Assistant and Associate Professor at the USC (University of Southern California) Keck School of Medicine and the foundation Plunkett Chair of Molecular Biology (Medicine) in the Faculty off Medicine at the University of Sydney.

Currently, Juergen chairs the Scientific Advisory Committee for the HUGO, the worldwide Human Genome Organization, and he also serves on the he Steering Committee of G2MC, the Global Genomic Medicine Collaborative, the Diagnostic Scientific Committee of IRDiRC, the International Rare Diseases Research Consortium, and various scientific and advisory boards and committees. Juergen cofounded ERCAL (Enfermedades Raras en América Latina y en el Caribe) a group of scientists, clinicians and patient advocates working on rare diseases in Latin America and the Caribbean. Furthermore, Juergen also serves on a dozen editorial boards and regularly reviews grant applications in various countries. He is an Associate Editor of Human Genomics and one of the guest editors for COVID-19 at the same journal.

Lastly, Juergen has lived in seven countries on four continents bringing a truly international perspective to his endeavours.  

All my publications can be found in Googgle Scholar: 

https://scholar.google.com/citations?hl=en&user=2G2mZVoAAAAJ&sortby=pubdate&scilu=&scisig=AMD79ooAAAAAY7ncudea2035YTsPomPCv7xpiXwNsJD-&gmla=AJsN-F7f4iEG_KZhutVo49mxajqLzDywvjhh2Gm2E9uDPm8Lt4nuXG5bkPM3XPAy8EGjLx5l-ir6oUfw_QNvCYTURA-oYDRqB2AHmjtm0gAgskjkmBjECZA&sciund=1453126103349343514

Experience

• 2019 to present - Adjunct Professor, James Cook University (Cairns)
• 2016 to 2019 - Vice Chancellor, Research and Innovation, Yachay Tech University (Urcuquí)
• 2015 - Professor, James Cook University (Townsville)
• 2012 to 2014 - Associate Dean Research, Faculty of Medicine, Health and Molecular Sciences, James Cook University (Townsville)
• 2011 to 2014 - Head of School, Pharmacy and Molecular Sciences, James Cook University (Townsville)
• 2005 to 2011 - Plunkett Chair of Molecular Biology (Medicine), University of Sydney (Camperdown)
• 2000 to 2005 - Associate Professor, University of Southern California (Los Angeles)
• 1992 to 2000 - Assistant Professor, University of Southern California (Los Angeles)
• 1991 - Research Instructor, Baylor College of Medicine (Houston)
• 1989 to 1991 - HHMI Postdoctoral Fellow, Baylor College of Medicine (Houston)
• 1982 to 1989 - PhD Student, Stanford University (Palo Alto)

Research Disciplines

• Genetics (3105)
• Cardiovascular medicine and haematology (3201)

Socio-Economic Objectives

• health (2099)
• Expanding knowledge (2801)

Awards

• 2004 - University of Southern California: STAR Mentor of the Year
• 1995 to 1996 - New Investigator (University of Southern California Liver Disease Research Center)
• 1992 to 1995 - Basil O' Connor Starter Scholar Award (March of Dimes)
• 1993 to 1994 - Zumberge Fellow (University of Southern California)

Fellowships

• 2005 to 2009 - Medical Foundation Fellow (University of Sydney)
• 1979 to 1980 - DAAD Fellowship

Memberships

• 2019 - Chair, Scientific Advisory Board, Fondation Erica Sauter
• 2017 - International Rare Diseases Research Consortium (IRDiRC), Diagnostic Scientific Committee (DSC)
• 2016 - Scientific Advisory Committee, the Golden Helix Foundation
• 2016 to 2021 - International Scientific Advisory Committee (ISAC), HVP (Human Variome Project)
• 2013 to 2020 - HuGO (Human Genome Organization International) Council

Other

• 2022 - Cochair, International Scientific Committee, Human Genome Meeting 2024, Rome. Italy
• 2022 - Cochair, Human Genome Meeting 2024, Rome. Italy
• 2022 - Steering Committee: G2MC (Global Genomic Collaborative)
• 2021 - Chair, Scientific Advisory Committee (SAC); Human Genome Organization (HUGO)
• 2020 - Frontiers in Genetics and Frontiers in Pharmacology (section on Pharmacogenetics and Pharmacogenomics)
• 2020 - Guest Editor for COVID-19 at Human Genomics
• 2014 - Associate Editor; Human Genomics
• 2019 - Visiting Professor, Tor Vergata University (Rome, Italy)
• 2005 to 2019 - International Advisory Committee: Pacific Rim Breast and Prostate Cancer Meeting series
• 2015 - Chair, Ron Ross Award, 6th Pacific Rim Breast and Prostate Cancer
• 2015 - Member, International Advisory Committee, 6th Pacific Rim Breast and Prostate Cancer Meeting; Oregon, USA
• 2013 to 2015 - HuGO (Human Genome Organisation International), Council
• 2013 - Visiting Professor, Tor Vergata University (Rome, Italy)
• 2009 to 2012 - Co-Chair, Human Genome Meeting (HGM 2012; HuGO; Human Genome Organisation); Local Organising Committee; Sydney, Australia
• 2008 to 2011 - Member, International Advisory Committee, 5th Pacific Rim Breast and Prostate Cancer Meeting; Kingscliff, NSW
• 2008 to 2011 - Local Organizing Committee: 5th Pacific Rim Breast and Prostate Cancer Meeting; Kingscliff, NSW
• 2008 to 2011 - Chair, Ron Ross Award, 5th Pacific Rim Breast and Prostate Cancer Meeting; Kingscliff, NSW
• 2008 - International Organizing Committee: 4th Pacific Rim Breast and Prostate Cancer Meeting; Whistler, Canada
• 2008 - Chair, Ron Ross Award, 4th Pacific Rim Breast and Prostate Cancer Meeting; Whistler, Canada
• 2005 to 2006 - Chair, Ronald K. Ross Award Committee; 3rd Pacific Rim Breast and Prostate Cancer Meeting; Fraser Island, Australia
• 2005 to 2006 - International Organizing Committee: 3rd Pacific Rim Breast and Prostate Cancer Meeting; Fraser Island, Australia
• 2001 to 2005 - Visiting Professor, Universidade Estadual de Campinas (Campinas S.P., Brazil)

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.

Journal Articles

• Biancolella M, Colona V, Mehrian-Shai R, Watt J, Luzzatto L, Novelli G and Reichardt J (2022) COVID-19 2022 update: transition of the pandemic to the endemic phase. Human Genomics, 16.
• Higgins J, Dalgleish R, den Dunnen J, Barsh G, Freeman P, Cooper D, Cullinan S, Davies K, Dorkins H, Gong L, Imoto I, Klein T, Korf B, Misra A, Paalman M, Ratzel S, Reichardt J, Rehm H, Tokunaga K, Weck K and Cutting G (2021) Verifying nomenclature of DNA variants in submitted manuscripts: guidance for journals. Human Mutation, 42 (1). pp. 3-7
• Novelli G, Biancolella M, Mehrian-Shai R, Colona V, Brito A, Grubaugh N, Vasiliou V, Luzzatto L and Reichardt J (2021) COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy. Human Genomics, 15.
• D’Angelo C, Hermes A, McMaster C, Prichep E, Richer É, van der Westhuizen F, Repetto G, Mengchun G, Malherbe H, Reichardt J, Arbour L, Hudson M, du Plessis K, Haendel M, Wilcox P, Lynch S, Rind S, Easteal S, Estivill X, Thomas Y and Baynam G (2020) Barriers and considerations for diagnosing rare diseases in Indigenous populations. Frontiers in Pediatrics, 8.
• Godri Pollitt K, Peccia J, Ko A, Kaminski N, Dela Cruz C, Nebert D, Reichardt J, Thompson D and Vasiliou V (2020) COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission. Human Genomics, 14 (1).
• Novelli G, Biancolella M, Mehrian-Shai R, Erickson C, Godri Pollitt K, Vasiliou V, Watt J and Reichardt J (2020) COVID-19 update: the first 6 months of the pandemic. Human Genomics, 14.
• Mehrian-Shai R, Reichardt J, Harris C and Toren A (2019) The gut-brain axis, paving the way to brain cancer. Trends In Cancer, 5 (4). pp. 200-207
• Zambrano-Mila M, Agathos S and Reichardt J (2019) Human genetics and genomics research in Ecuador: historical survey, current state, and future directions. Human Genomics, 13.
• Mehrian-Shai R, Yalon M, Moshe I, Barshack I, Nass D, Jacob J, Dor C, Reichardt J, Constantini S and Toren A (2016) Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis. BMC Genomics, 17. pp. 1-11
• Price D, Chau C, Till C, Goodman P, Leach R, Johnson-Pais T, Hsing A, Hoque A, Parnes H, Schenk J, Tangen C, Thompson I, Reichardt J and Figg W (2016) Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: results from the Prostate Cancer Prevention Trial. Cancer, 122 (15). pp. 2332-2340
• Schenk J, Till C, Hsing A, Stanczyk F, Gong Z, Neuhouser M, Reichardt J, Hoque A, Figg W, Goodman P, Tangen C and Thompson I (2016) Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial. Cancer Causes and Control, 27 (2). pp. 175-182
• Arthur J, Cheung F and Reichardt J (2015) Single nucleotide differences (SNDs) continue to contaminate the dbSNP database with consequences for human genomics and health. Human Mutation, 36 (2). pp. 196-199

More

ResearchOnline@JCU stores 35+ research outputs authored by Prof Juergen Reichardt from 2010 onwards.

The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.